Literature DB >> 15241793

The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.

Bernhard Steiner1, Kaspar Truninger, Javier Sanz, André Schaller, Sabina Gallati.   

Abstract

Classic cystic fibrosis (CF) is caused by two loss-of-function mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, whereas patients with nonclassic CF have at least one copy of a mutant gene that retains partial function of the CFTR protein. In addition, there are several other phenotypes associated with CFTR gene mutations, such as idiopathic chronic pancreatitis. In CFTR-associated disorders and in nonclassic CF, often only one CFTR mutation or no CFTR mutations can be detected. In this study, we screened 23 patients with CFTR-associated disorders for CFTR mutations by complete gene testing and quantitative transcript analysis. Mutations were found in 10 patients. In cells from respiratory epithelium, we detected aberrant splicing of CFTR mRNA in all investigated individuals. We observed a highly significant association between the presence of coding single-nucleotide polymorphisms (coding SNPs, or cSNPs) and increased skipping of exon 9 and 12. This association was found both in patients and in normal individuals carrying the same cSNPs. The cSNPs c.1540A>G, c.2694T>G, and c.4521G>A may have affected pre-mRNA splicing by changing regulatory sequence motifs of exonic splice enhancers, leading to lower amounts of normal transcripts. The analysis of CFTR exons indicated that less frequent and weak exonic splicing enhancer (ESE) motifs make exon 12 vulnerable to skipping. The number of splice variants in individuals with cSNPs was similar to previously reported values for the T5 allele, suggesting that cSNPs may enhance susceptibility to CFTR related diseases. In addition, cSNPs may be responsible for variation in the phenotypic expression of CFTR mutations. Quantitative approaches rather than conventional genomic analysis are required to interpret the role of cSNPs. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241793     DOI: 10.1002/humu.20064

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

1.  Synonymous SNPs provide evidence for selective constraint on human exonic splicing enhancers.

Authors:  David B Carlini; Jordan E Genut
Journal:  J Mol Evol       Date:  2005-11-30       Impact factor: 2.395

2.  CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.

Authors:  Molly B Sheridan; Timothy W Hefferon; Nulang Wang; Christian Merlo; Carlos Milla; Drucy Borowitz; Eric D Green; Peter J Mogayzel; Garry R Cutting
Journal:  J Med Genet       Date:  2010-11-20       Impact factor: 6.318

3.  Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease.

Authors:  Fanggeng Zou; Rangaraj K Gopalraj; Johann Lok; Haiyan Zhu; I-Fang Ling; James F Simpson; H Michael Tucker; Jeremiah F Kelly; Samuel G Younkin; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; David A Bennett; Julia E Crook; Steven G Younkin; Steven Estus
Journal:  Hum Mol Genet       Date:  2007-12-08       Impact factor: 6.150

4.  Alternative approach to a heavy weight problem.

Authors:  Amir Goren; Eddo Kim; Maayan Amit; Ron Bochner; Galit Lev-Maor; Nadav Ahituv; Gil Ast
Journal:  Genome Res       Date:  2007-12-20       Impact factor: 9.043

5.  Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.

Authors:  Karsten Bork Nielsen; Suzette Sørensen; Luca Cartegni; Thomas Juhl Corydon; Thomas Koed Doktor; Lisbeth Dahl Schroeder; Line Sinnathamby Reinert; Orly Elpeleg; Adrian R Krainer; Niels Gregersen; Jørgen Kjems; Brage Storstein Andresen
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

6.  Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis.

Authors:  Laia Masvidal; Susana Igreja; Maria D Ramos; Antoni Alvarez; Javier de Gracia; Anabela Ramalho; Margarida D Amaral; Sara Larriba; Teresa Casals
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

7.  Long-term gas exchange characteristics as markers of deterioration in patients with cystic fibrosis.

Authors:  Richard Kraemer; Philipp Latzin; Isabelle Pramana; Pietro Ballinari; Sabina Gallati; Urs Frey
Journal:  Respir Res       Date:  2009-11-12

8.  A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol.

Authors:  Haiyan Zhu; H Michael Tucker; Karrie E Grear; James F Simpson; Alisa K Manning; L Adrienne Cupples; Steven Estus
Journal:  Hum Mol Genet       Date:  2007-05-21       Impact factor: 6.150

9.  Clinical and molecular characterization of the potential CF disease modifier syntaxin 1A.

Authors:  Thomas von Kanel; Frauke Stanke; Melanie Weber; Andre Schaller; Julien Racine; Richard Kraemer; Marc Chanson; Burkhard Tümmler; Sabina Gallati
Journal:  Eur J Hum Genet       Date:  2013-04-10       Impact factor: 4.246

10.  Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing.

Authors:  K B Douglas; D C Windels; J Zhao; A V Gadeliya; H Wu; K M Kaufman; J B Harley; J Merrill; R P Kimberly; G S Alarcón; E E Brown; J C Edberg; R Ramsey-Goldman; M Petri; J D Reveille; L M Vilá; P M Gaffney; J A James; K L Moser; M E Alarcón-Riquelme; T J Vyse; G S Gilkeson; C O Jacob; J T Ziegler; C D Langefeld; D Ulgiati; B P Tsao; S A Boackle
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.